Profile data is unavailable for this security.
About the company
Agilent Technologies, Inc. provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business. Its life sciences and applied markets business segment offers instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products, as well as enable customers in the clinical and life sciences research areas to interrogate samples at the molecular level. Its diagnostics and genomics business segment includes the reagent partnership, pathology, companion diagnostics, genomics and the nucleic acid solutions businesses. Its Agilent CrossLab business segment spans the entire lab with its consumables and services portfolio.
- Revenue in USD (TTM)5.34bn
- Net income in USD719.00m
- Incorporated1999
- Employees16.40k
- LocationAgilent Technologies Inc5301 Stevens Creek BlvdSANTA CLARA 95051-7201United StatesUSA
- Phone+1 (408) 345-8886
- Fax+1 (408) 345-8474
- Websitehttps://www.agilent.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fortive Corp | 7.19bn | 508.20m | 23.97bn | 25.00k | 47.64 | 3.12 | 24.51 | 3.33 | 1.49 | 1.53 | 21.12 | 22.76 | 0.4247 | 5.18 | 5.66 | 287,576.00 | 3.41 | 7.91 | 4.14 | 9.60 | 51.60 | 50.23 | 8.03 | 13.03 | 1.02 | 5.62 | 0.4257 | 8.52 | 13.44 | 2.93 | -24.59 | -5.77 | 1.86 | -- |
| Keysight Technologies Inc | 4.22bn | 627.00m | 27.32bn | 13.90k | 44.28 | 8.25 | 28.67 | 6.47 | 3.32 | 3.32 | 22.30 | 17.79 | 0.6099 | 2.31 | 6.63 | 303,669.10 | 9.06 | 6.72 | 10.67 | 8.14 | 60.01 | 56.72 | 14.85 | 10.00 | 2.42 | 10.69 | 0.3518 | 0.00 | -1.91 | 8.13 | 0.9662 | 4.10 | 4.93 | -- |
| AMETEK, Inc. | 4.65bn | 872.19m | 28.56bn | 18.10k | 32.83 | 5.01 | 25.34 | 6.15 | 3.78 | 3.78 | 20.14 | 24.79 | 0.4728 | 5.03 | 6.10 | 256,679.70 | 8.88 | 8.66 | 10.18 | 10.12 | 34.54 | 36.76 | 18.77 | 15.01 | 1.47 | 11.95 | 0.3293 | 15.31 | 6.45 | 5.10 | 12.42 | 8.06 | 7.49 | 11.16 |
| Mettler-Toledo International Inc. | 2.99bn | 579.19m | 29.04bn | 16.20k | 51.35 | 65.54 | 43.05 | 9.71 | 23.77 | 23.77 | 122.85 | 18.62 | 1.11 | 4.36 | 5.84 | 184,639.50 | 21.44 | 19.35 | 29.56 | 26.91 | 58.18 | 57.40 | 19.36 | 16.67 | 0.9868 | 19.65 | 0.7343 | 0.00 | 2.49 | 3.89 | 8.70 | 10.65 | 1.72 | -- |
| Agilent Technologies Inc | 5.34bn | 719.00m | 38.96bn | 16.40k | 55.15 | 7.97 | 37.94 | 7.30 | 2.30 | 2.30 | 17.10 | 15.92 | 0.5597 | 3.58 | 5.43 | 325,548.80 | 7.54 | 8.89 | 9.26 | 10.55 | 53.10 | 53.68 | 13.47 | 15.79 | 1.84 | 17.42 | 0.3262 | 24.68 | 3.41 | 5.74 | -32.87 | 10.42 | 3.96 | 10.26 |
| Roper Technologies Inc | 5.42bn | 1.57bn | 45.09bn | 16.46k | 28.98 | 4.44 | 22.10 | 8.33 | 14.84 | 14.84 | 51.33 | 96.89 | 0.2612 | 9.28 | 5.65 | 329,076.60 | 7.55 | 7.14 | 8.32 | 7.99 | 64.05 | 62.42 | 28.89 | 21.34 | 0.6373 | 7.10 | 0.4885 | 15.71 | 3.38 | 8.62 | 90.04 | 22.30 | 10.81 | 18.25 |
| Emerson Electric Co. | 16.79bn | 1.97bn | 50.22bn | 83.50k | 25.88 | 5.97 | 17.66 | 2.99 | 3.24 | 3.24 | 27.68 | 14.06 | 0.774 | 5.13 | 5.38 | 201,053.90 | 9.17 | 9.21 | 12.62 | 13.31 | 41.81 | 42.36 | 11.85 | 11.71 | 1.19 | 16.78 | 0.4698 | 64.23 | -8.64 | 0.6512 | -14.79 | -4.83 | -1.76 | 1.25 |
| Illumina, Inc. | 3.24bn | 638.00m | 52.75bn | 7.70k | 84.02 | 11.22 | 64.33 | 16.29 | 4.30 | 4.30 | 21.84 | 32.19 | 0.4468 | 2.41 | 6.44 | 420,519.50 | 8.80 | 13.71 | 10.00 | 17.11 | 69.02 | 68.98 | 19.70 | 24.54 | 3.51 | -- | 0.1997 | 0.00 | 6.30 | 13.74 | 19.71 | 23.18 | 8.00 | -- |
| Holder | Shares | % Held |
|---|---|---|
| T. Rowe Price Associates, Inc. (Investment Management)as of 30 Sep 2020 | 23.69m | 7.72% |
| The Vanguard Group, Inc.as of 30 Sep 2020 | 22.89m | 7.46% |
| BlackRock Fund Advisorsas of 30 Sep 2020 | 15.18m | 4.95% |
| SSgA Funds Management, Inc.as of 30 Sep 2020 | 13.65m | 4.45% |
| Pershing Square Capital Management LPas of 30 Sep 2020 | 12.25m | 3.99% |
| Wellington Management Co. LLPas of 30 Sep 2020 | 8.60m | 2.80% |
| Harris Associates LPas of 30 Sep 2020 | 5.83m | 1.90% |
| Artisan Partners LPas of 30 Sep 2020 | 5.40m | 1.76% |
| Geode Capital Management LLCas of 30 Sep 2020 | 4.99m | 1.63% |
| State Farm Investment Management Corp.as of 30 Sep 2020 | 4.64m | 1.51% |
